CT in 15 Patients With Platelet Disorders
| Platelet Disorder . | Patients . | CT (sec) . | |
|---|---|---|---|
| ADP . | Epi . | ||
| Glanzmann thrombasthenia (n = 2) | 1 | >250 | >250 |
| Pseudo (“platelet”)-vWD (n = 3) | 2 1 2 3 | >250 >250 >250 >250 | >250 >250 >250 >250 |
| Storage pool disease (n = 4) | 1 2 3 | >250 >250 >250 | >250 >250 >250 |
| 4 | >250 | >250 | |
| Aspirin-like defect (n = 6) | 1 2 3 | 150 130 121 | >250 >250 >250 |
| 4 | 115 | 228 | |
| 5 | 104 | 216 | |
| 6 | 81 | 210 | |
| Normal range (mean ± 2 SD) | 59-120 | 80-160 | |
| Platelet Disorder . | Patients . | CT (sec) . | |
|---|---|---|---|
| ADP . | Epi . | ||
| Glanzmann thrombasthenia (n = 2) | 1 | >250 | >250 |
| Pseudo (“platelet”)-vWD (n = 3) | 2 1 2 3 | >250 >250 >250 >250 | >250 >250 >250 >250 |
| Storage pool disease (n = 4) | 1 2 3 | >250 >250 >250 | >250 >250 >250 |
| 4 | >250 | >250 | |
| Aspirin-like defect (n = 6) | 1 2 3 | 150 130 121 | >250 >250 >250 |
| 4 | 115 | 228 | |
| 5 | 104 | 216 | |
| 6 | 81 | 210 | |
| Normal range (mean ± 2 SD) | 59-120 | 80-160 | |